AIDS drug could also fight herpes virus
September 24th, 2010 - 2:12 pm ICT by ANIWashington, Sep 24 (ANI): A drug approved in 2007 for the treatment of AIDS- raltegravir or Isentress-could also play a role in preventing the herpes virus, found a new study.
Sold by Merck, the drug cancels the function of an essential protein for the replication of one kind of herpes virus, said scientists at the Institute for Research in Biomedicine (IRB Barcelona).
Headed by the coordinator of the Structural and Computational Biology Programme, Miquel Coll, the study is the first step towards the development of a drug against the entire herpesvirus family.
“These results have a clear medical impact for three reasons. First, humans do not have the viral protein that is affected, thus this would allow a highly specific drug that does not show the secondary effects that other drugs may have. Second, the inhibitor is not toxic for humans when administered at therapeutic concentrations because it is already on the market and thus toxicity tests are facilitated; and third, we have data that indicate that all herpes viruses have this protein. Therefore, it could be a valid target against all Herpesviridae,” explained Miquel Coll, also a CSIC research professor.
The drug cancels the function of an essential protein for the replication of the virus.
Herpesviruses include pathogens such as herpes simplex 1 and 2, the virus that causes chickenpox otherwise known as zoster virus, the Epstein-Barr virus -associated with several types of cancer -, the roseola virus, the cytomegalovirus and the herpes virus associated with Kaposi sarcoma -in AIDS patients.
The study is published in the journal Proceedings of the National Academies of Sciences (PNAS). (ANI)
- Shingles vaccine cuts risk by 55 pc: Study - Jan 12, 2011
- Scientists unravel herpes virus protein structure - Jul 27, 2010
- A compound for healing painful blisters - Apr 25, 2011
- Diarrhea-causing bacteria turned into antiviral gene therapy agent - Feb 08, 2011
- Map of herpes virus protein suggests new target for antiviral drugs - Jul 07, 2010
- Novel anti-shingles agent developed - Apr 22, 2011
- Protein knocks out HIV by starving it of raw materials - Feb 13, 2012
- New strategy could increase antiviral drugs' effectiveness - Jul 20, 2010
- HIV replication process could be different than previously thought - Jul 16, 2010
- Shingles 'raises stroke risk in adults' - Oct 09, 2009
- How HIV reactivates after entering a dormant state - Feb 27, 2011
- Chicken pox vaccine cuts shingles risk in kids - Dec 05, 2009
- Scientists uncover clues to cancer development in AIDS patients - Jun 18, 2009
- Breakthrough may lead to new HIV drugs - Feb 01, 2010
- Drug for rare childhood cancer may help prevent prostate cancer spread - Apr 30, 2011
Tags: aids drug, aids patients, computational biology, epstein barr virus, herpes simplex 1, herpes simplex 1 and 2, herpes viruses, herpesviridae, herpesvirus family, isentress, journal proceedings, medical impact, miquel coll, proceedings of the national academies of sciences, raltegravir, roseola virus, toxicity tests, treatment of aids, valid target, viral protein
